Sotera Health Company Appoints Vincent K. Petrella as Lead Independent Director
Sotera Health Company (Nasdaq: SHC) has appointed Vincent K. Petrella as Lead Independent Director, effective January 2, 2025. Petrella, who has been serving on the company's Board of Directors since 2020, will act as a key liaison among the Board, management, and shareholders.
The appointment leverages Petrella's decades of public company executive leadership and board experience, including his role as chairperson of Sotera Health's Audit Committee. Michael B. Petras, Jr., Sotera Health Chairman and CEO, highlighted Petrella's valuable experience, insight, and engagement since joining the Board.
Sotera Health Company (Nasdaq: SHC) ha nominato Vincent K. Petrella come Direttore Indipendente Principale, a partire dal 2 gennaio 2025. Petrella, che fa parte del Consiglio di Amministrazione della società dal 2020, agirà come un collegamento chiave tra il Consiglio, la direzione e gli azionisti.
La nomina sfrutta i decenni di esperienza di Petrella nella leadership esecutiva di aziende pubbliche e nel consiglio di amministrazione, incluso il suo ruolo come presidente del Comitato di Controllo di Sotera Health. Michael B. Petras, Jr., Presidente e CEO di Sotera Health, ha sottolineato l'esperienza, la visione e l'impegno prezioso di Petrella da quando è entrato nel Consiglio.
Sotera Health Company (Nasdaq: SHC) ha designado a Vincent K. Petrella como Director Independiente Principal, efectivo a partir del 2 de enero de 2025. Petrella, quien ha estado sirviendo en la Junta Directiva de la compañía desde 2020, actuará como un enlace clave entre la Junta, la dirección y los accionistas.
El nombramiento aprovecha las décadas de experiencia de Petrella en liderazgo ejecutivo de empresas públicas y en juntas directivas, incluyendo su rol como presidente del Comité de Auditoría de Sotera Health. Michael B. Petras, Jr., Presidente y CEO de Sotera Health, destacó la valiosa experiencia, percepción y compromiso de Petrella desde que se unió a la Junta.
소테라 헬스 컴퍼니 (Nasdaq: SHC)는 빈센트 K. 페트렐라를 독립 이사장으로 임명하며, 2025년 1월 2일부터 효력을 발휘합니다. 페트렐라는 2020년부터 회사의 이사회에서 활동해왔으며, 이사회, 경영진 및 주주들 간의 주요 연결 고리 역할을 맡게 됩니다.
이번 임명은 페트렐라의 수십 년에 걸친 상장 회사 임원 리더십 및 이사회 경험을 활용하며, 소테라 헬스의 감사위원회 위원장 역할도 포함됩니다. 소테라 헬스의 회장 겸 CEO인 마이클 B. 페트라스 주니어는 페트렐라가 이사회에 합류한 이후의 귀중한 경험, 통찰 및 참여를 강조했습니다.
Sotera Health Company (Nasdaq: SHC) a nommé Vincent K. Petrella comme Administrateur Indépendant Principal, avec effet au 2 janvier 2025. Petrella, qui siège au conseil d'administration de la société depuis 2020, agira en tant que liaison clé entre le conseil, la direction et les actionnaires.
Cette nomination tire parti des décennies d'expérience de Petrella en matière de leadership exécutif dans des sociétés cotées en bourse et d'expérience au sein de conseils d'administration, y compris son rôle de président du Comité d'Audit de Sotera Health. Michael B. Petras, Jr., Président et CEO de Sotera Health, a souligné l'expérience précieuse, les perspectives et l'engagement de Petrella depuis son arrivée au Conseil.
Sotera Health Company (Nasdaq: SHC) hat Vincent K. Petrella mit Wirkung zum 2. Januar 2025 zum Lead Independent Director ernannt. Petrella, der seit 2020 im Vorstand des Unternehmens tätig ist, wird eine Schlüsselverbindung zwischen dem Vorstand, dem Management und den Aktionären bilden.
Die Ernennung nutzt Petrellas jahrzehntelange Erfahrung in der Führung öffentlicher Unternehmen und in Vorständen, einschließlich seiner Rolle als Vorsitzender des Prüfungsausschusses von Sotera Health. Michael B. Petras, Jr., Vorsitzender und CEO von Sotera Health, hob Petrellas wertvolle Erfahrung, Einsichten und Engagement seit seinem Eintritt in den Vorstand hervor.
- Appointment of experienced board member with deep company knowledge
- Enhanced corporate governance through Lead Independent Director role
- Continuity in leadership with internal promotion from existing board member
- None.
CLEVELAND, Ohio, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry, is pleased to announce today the appointment of Vincent K. Petrella as Lead Independent Director, effective January 2, 2025.
Mr. Petrella, who has served on Sotera Health Company’s Board of Directors since 2020, brings a wealth of experience and a deep understanding of the Company’s strategic vision and operations. In this newly appointed role, Mr. Petrella will serve as a key liaison among the Board, management and shareholders.
Mr. Petrella has decades of public company executive leadership and board experience. “Since joining our Board, Vince’s experience, insight and engagement have been invaluable as chairperson of our Audit Committee. We are delighted to benefit from his continued knowledge and guidance as our Lead Independent Director,” said Michael B. Petras, Jr., Sotera Health Chairman and Chief Executive Officer.
“It is a great privilege to engage with Sotera Health leadership and the Board, and I’m excited by this opportunity to lead in an expanded way,” Mr. Petrella said. “I appreciate the confidence of the Board and look forward to continuing to support Sotera Health and drive shareholder value.”
About Vincent K. Petrella
Mr. Petrella served as the Executive Vice President, Chief Financial Officer and Treasurer at Lincoln Electric Holdings, Inc., a welding, cutting and brazing products manufacturer from 2004 until April 2020. He is currently a board member of Applied Industrial Technologies, Inc. and the Gorman-Rupp Company.
About Sotera Health
Sotera Health Company is a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry. Sotera Health goes to market through three businesses – Sterigenics®, Nordion® and Nelson Labs®. Sotera Health is committed to its mission, Safeguarding Global Health®.
Updates can be found from time to time on recent developments in matters relevant to investors on the Investor Relations section of the Company’s website at Investor Relations | Sotera Health. For developments related to Ethylene Oxide, updates can be found at Ethylene Oxide | Sotera Health.
INVESTOR RELATIONS CONTACT
Jason Peterson
Vice President, Investor Relations & Treasurer
IR@soterahealth.com
MEDIA CONTACT
Kristin Gibbs
Chief Marketing Officer
kgibbs@soterahealth.com
Source: Sotera Health Company
FAQ
When does Vincent Petrella start as Lead Independent Director at Sotera Health (SHC)?
How long has Vincent Petrella been on Sotera Health's (SHC) Board of Directors?
What is Vincent Petrella's previous role at Sotera Health (SHC)?
What will be Vincent Petrella's main responsibilities as Lead Independent Director at SHC?
